With more than 40 million men dealing with an enlarged prostate (BPH), chances are either you or someone you know is experiencing the frequent urge to go to the bathroom or slowed urinary flow. For 69 ...
PLEASANTON, Calif., Aug. 20, 2020 /PRNewswire-PRWeb/ -- NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today ...
PLEASANTON, Calif., April 23, 2020 /PRNewswire-PRWeb/ -- NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today ...
WAYNE, Pa., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the results of four studies that were accepted at the ICS 2020 Annual Meeting – Online reinforcing the ...
WAYNE, Pa.--(BUSINESS WIRE)--NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced the publication of ...
Five Studies Show Significant Relief and Improved Quality of Life with UroLift System The “Real-World Experience” study, which enrolled 156 patients at the Norfolk & Norwich University Hospital in the ...
“Arriving at the intersection of effective BPH treatment, patient priorities and available technology can be a daunting task,” said Mr. Olly Kayes, MD, Honorary Senior Lecturer at the University of ...
UroLift® System, a proven treatment for Benign Prostatic Hyperplasia (BPH), now reimbursed in France
A surgical option which is minimally invasive and available as same-day outpatient procedure1,2,3 Following a positive Haute Autorité de Santé (HAS) assessment, a procedure code has been granted ...
WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced ...
WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American ...
Both Rezūm® and Urolift® are relatively new treatments for BPH, as countries begin reimbursing for these treatments, the market will grow significantly.” — Dr. Kamran Zamanian, Senior Partner and CEO ...
UroLift is a minimally invasive treatment option for benign prostatic hyperplasia (BPH), also called enlarged prostate. Medicare covers the UroLift procedure when a doctor deems it medically necessary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results